Patent · US Active

Antisense IAP nucleobase oligomers and uses thereof

US7638620B2 · kind B2 · utility

1Cited by
35References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2006
Grant dateDec 29, 2009
Priority date
Expiry dateFeb 27, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis and treat proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.